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1. Introduction 
Factor IX is a single-chain glycoprotein involved in 
the intrinsic pathway of blood coagulation. The molecu- 
lar characteristics of factor IX and the mechanism of 
its activation by factor XI, (activated factor XI) have 
recently been described [ 1,2] . In the presence of factor 
VIII, calcium, and phospholipid, factor IX, catalyzes 
the conversion of factor X to X,. Factor X, in the 
presence of factor V, calcium, and phospholipid in 
turn converts prothrombin to thrombin. Factor X, 
and thrombin are both inactivated by diisopropyl- 
phosphorofluoridate (DFP), but the same has not been 
established for factor IX,. Factor X, and thrombin 
are homologous with other mammalian serine 
proteases [3]. The amino terminal regions of factor 
IX, prothrombin, and the light chain of factor X are 
also homologous, but factor IX is immunologically 
distinct [4]. Nevertheless, evidence is presented here 
showing that considerable homology exists between 
bovine factors IX and X and prothrombin, suggesting 
that factor IX, has evolved from the same precursor 
and therefore is probably also a serine protease. 
2. Materials and methods 
Bovine factor IX was prepared and activated accord- 
ing to the method of Fujikawa et al. [ 1,2] . The protein 
was reduced and pyridyiethylated as described by 
Friedman et al. [5]. The light and heavy chains and 
the activation peptide of factor IX, were fractionated 
by gel filtration [ 21. Digestion with cyanogen bromide 
was carried out as described [3] and the fragments 
separated by gel filtration on Sephadex G-75. The 
smaller fragments were further purified by recycling on 
Sephadex G-50 ‘superfine’. Both columns were eluted 
with 9% formic acid. Automatic sequence determina- 
tion was carried out with the Beckman Sequencer 
(model 890B) according to the method of Edman and 
Begg [6], as modified by Hermodson et al. [7]. 4- 
Vinylpyridine monomer (practical grade) was a product 
of J. T. Baker Chemical Co. and was further purified 
by vacuum distillation and stored at -20°C in the dark. 
3. Results and discussion 
The sequence of the first 15 residues of the heavy 
chain of factor IX, is shown in fig. 1 together with the 
sequences of the corresponding regions of thrombin [ 81 
and the heavy chain of factor X, [33. Eight of these 
15 residues are identical in all three proteins, and many 
of the remaining residues represent conservative 
substitutions. 
Factor IXo 
Factor Xo 
Thrombin 
Fig. 1. Amino-termkal sequences of the heavy chains of bovine factors IX, and X, and the B-chain of thrombin. Residues enclosed 
by solid lines are identical. 
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Fig. 2. Gel filtration of the cyanogen bromide digest of S-pyridylethyl bovine factor IX. The lyophilized digest (100 mg) was 
applied to a 2.5 X 115 cm column of Sephadex G-75 and eluted with 9% formic acid. The flow rate was 35 ml/hr; fractions were 
collected every 8.7 min. Fractions were combined as indicated by the black bars and peptides were recovered by lyophilization. 
The column was monitored at 280 nm with an LKB Uvicord-II UV Absorptiometer (model 8300). 
To further compare the sequence of factor IX with 
those of factor X and prothrombin, factor IX was 
fragmented with cyanogen bromide, Amino acid 
analysis yields three methionines [ 11, and thus four 
major fragments would be expected. The fractionation 
of the digest by gel filtration is shown in fig. 2. Peaks 
CB-I through CB-V were analyzed with the Sequencer. 
Preliminary evidence indicates that CB-II is a fragment 
produced in low amounts resulting from the presence 
of a poorly-cleaved methionyl peptide bond. No amino 
acids were found in CB-VI after acid hydrolysis. Frag- 
r I 
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ment CB-IV was found to correspond to the regions of 
factor X, and thrombin containing the DFP-reactive 
serine. The sequence of the first 24 residues of CB-IV 
is shown in fig. 3 together with the homologous 
sequences of factor X, [3] and thrombin [8] . Of these 
24 residues, 14 are identical to those in the other two 
proteins. 
The functional roles of the light chains of factors 
IX, and X are not yet known. However, factor X binds 
calcium [9] and the amino acid composition of a 
calcium-binding peptide isolated from factor X [lo] 
I I 
,Phe-Cys-Alo-Gly-Tyr~tiis---Glu-Gly~Gly-Lys~---/sp~ 
Phe -Cys-Ala - Gly-Tyr Lys-Pro-Gly-Glu Gly -Lys Arg-Gly Asp-Ala 
Phe-Cys-Alo -Gly-Tyr Asp---Thr-GIn-Pro-Giu---- Asp-Ala 
Fig. 3. Amino acid sequence of factor IX compared to homologous sequences urrounding the DFP-reactive serine in thrombin and 
factor X. The serine is shown in capital letters. Dashes indicate gaps inserted to optimize homology among the sequences. Residues 
enclosed by solid lines are identical. 
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Fig. 4. A~no-terming sequence of fragment CB-I from factor IX compared to the homologous sequence in the light chain of factor 
X. The numbers refer to the sequence of the light chain of factor X [ 111. Residues enclosed by solid lines are identical. 
closely corresponds to residues 5 through 43 of the 
light chain [ 1 I] . This region of factor X is known to 
be homologous to the amino terminal regions of factor 
IX and prothrombin [4], the latter also being a calcium- 
binding protein f 121. In addition, the light chains of 
factor IX, and X are similar in size [Z] . Further evidence 
of homology between these light chains is shown in 
fig. 4. The amino terminal sequence of CB-I of factor 
IX is aligned with residues 6 1 through 80 of the light 
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Fig. 5. Comparison of sequence homology and length of the 
polypeptide chains of bovine prothrombin, factor X, factor 
IX, and trypsinogen. The molecular weights are given for the 
intact proteins. The length of each bar is proportional to the 
molecular weight of the peptide portion of the protein, without 
carbohydrate (E. W. Davie and K. Titani, personal communica- 
tion). Stippled areas indicate known homologous sequences. 
The large dots indicate the positions of the DFP-reactive 
serine (except in the case of factor IX where its reactivity has 
not been proven). Activation at the site indicated yields the 
B-chain of thrombin, the hkavy chains of factors X, and IXa, 
and trypsin, respectively. 
chain of factor X [ 113 . Of these 20 residues, 11 are 
identical in both proteins. It is thus apparent that the 
light chain re8ions of factors IX, and X are homologous. 
The relationships among the polypeptide chains of 
bovine prothrombin, factors X and IX, and trypsinogen 
are diagramed in fig. 5. The amino terminal regions 
of prothrombin, factor IX, and the light chain of 
factor X are homologous, as are the four active enzymes 
themselves. Thrombin is somewhat larger than trypsin, 
the additions residues occurring as several short inser- 
tions [8,13,14]. Complete comparison of the regions 
preceding the sites of activation in the clotting factors 
is not yet possible. However, the correlation of seg- 
ments preceding the active enzymes indicates differences 
in linear separation of the homologous regions. This is 
especially striking when prothrombin and factor IX are 
compared. Since both zymogens are single chains, 
there must have occurred either a massive single or 
several smaller additions or deletions during the 
divergent evolution of these two proteins. Since factor 
X is also smaller than prothrombin but contains two 
chains, it is possible either that factor X has evolved 
from a single chain shorter than prothrombin or that 
a peptide segment has been lost prior to isolation. 
Analogously, since factor IX is somewhat shorter than 
factor X, an insertion or deletion may have occurred 
also. 
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